ECCO IBD Curriculum

6.2. Knows the modes of delivery of different drug therapies and their advantages and disadvantages.
Anti-TNF agents15th IBD Intensive Advanced Course
Year: 2017
Authors: Baert F.
Anti TNF drug levels, Anti drug antibodies, Therapeutic drug monitoring, Anti-TNF agents
Files: 1
Medical management of acute severe Ulcerative Colitis15th IBD Intensive Advanced Course
Year: 2017
Authors: Lees C.
MDT, Ileo anal pouch procedure, Laparoscopic surgery, Anti- TNF agents, Ciclosporin, Corticosteroids
Files: 1
Steroids15th IBD Intensive Advanced Course
Year: 2017
Authors: Vavricka S.
Budesonide, Corticosteroids
Files: 1
Transatlantic Talking Heads: Perspectives on BiosimilarsTalking Heads
Year: 2017
Authors: David Rubin, Millie Long, Silvio Danese

Talking Heads recorded by the Crohn's and Colitis Foundation in cooperation with ECCO.

Transatlantic Talking Heads: The role of azathioprine monotherapy in Crohn'sTalking Heads
Year: 2017
Authors: James Lindsay, Peter Irving, Bruce Sands
Ustekinumab15th IBD Intensive Advanced Course
Year: 2017
Authors: Ferrante M.
Crohn's disease, Disease activity Indices, Ustekinumab, Colonoscopy
Files: 1
Vedolizumab15th IBD Intensive Advanced Course
Year: 2017
Authors: Lindsay J.
Therapeutic drug monitoring, Vedolizumab
Files: 1
Management of Patients on ThiopurinesTalking Heads
Year: 2015
Authors: Antonio Lopéz San-Román, Eugeni Domènech
Methotrexate Why, When, How?Talking Heads
Year: 2015
Authors: Antonio Lopez San Roman, David Laharie,Guillaume Savoye